Terms: = Endocrine gland cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Diagnosis
30 results:
1. Trends in access to minimally invasive pancreaticoduodenectomy for pancreatic cancers.
Seldomridge AN; Rasic G; Papageorge MV; Ng SC; de Geus SWL; Woods AP; McAneny D; Tseng JF; Sachs TE
HPB (Oxford); 2024 Mar; 26(3):333-343. PubMed ID: 38087704
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
[TBL] [Abstract] [Full Text] [Related]
3. The association of macronutrient quality and its interactions with energy intake with survival among patients with ovarian cancer: results from a prospective cohort study.
Zheng G; Gong TT; Ma QP; Wei YF; Du ZD; Zhao JQ; Zou BJ; Yan S; Liu FH; Sun ML; Xiao Q; Gao S; Wu QJ; Zhao YH
Am J Clin Nutr; 2023 Jun; 117(6):1362-1371. PubMed ID: 37001589
[TBL] [Abstract] [Full Text] [Related]
4. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Biomarkers for Ovarian cancer diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
Zheng Q; Ye H; Zhong H; Wang M
Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
[TBL] [Abstract] [Full Text] [Related]
6. [Role of Contrast-enhanced Ultrasound in Distinguishing between Benign and Malignant Thyroid Nodules with Calcification].
Wang ZF; Shang J; Zhu Y; Liu B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):905-910. PubMed ID: 34980330
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.
Baran JA; Bauer AJ; Halada S; Mostoufi-Moab S; Isaza A; Robbins S; Franco AT; Adzick NS; Patel T; Kazahaya K
Thyroid; 2021 Dec; 31(12):1786-1793. PubMed ID: 34714171
[No Abstract] [Full Text] [Related]
8. Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective.
Zhang Y; Wang X; Chen X
Aging (Albany NY); 2021 Jan; 13(2):3112-3145. PubMed ID: 33493131
[TBL] [Abstract] [Full Text] [Related]
9. Pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients.
Hoogenboom SA; Bolan CW; Chuprin A; Raimondo MT; van Hooft JE; Wallace MB; Raimondo M
Pancreatology; 2021 Mar; 21(2):428-433. PubMed ID: 33485792
[TBL] [Abstract] [Full Text] [Related]
10. Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
Majidi A; Na R; Jordan SJ; De Fazio A; Webb PM;
Int J Cancer; 2021 Apr; 148(7):1608-1615. PubMed ID: 33034053
[TBL] [Abstract] [Full Text] [Related]
11. cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
Kaliszewski K; Diakowska D; Wojtczak B; Rudnicki J
PLoS One; 2020; 15(7):e0236257. PubMed ID: 32692768
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
[TBL] [Abstract] [Full Text] [Related]
13. Estimates of Overall Survival in Patients With cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract] [Full Text] [Related]
14. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
[TBL] [Abstract] [Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract] [Full Text] [Related]
16. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
Mete O; Gucer H; Kefeli M; Asa SL
Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
[TBL] [Abstract] [Full Text] [Related]
18. Methylation markers differentiate thyroid cancer from benign nodules.
Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
[TBL] [Abstract] [Full Text] [Related]
19. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract] [Full Text] [Related]
20. [Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine chemotherapy: clinical characteristics of long-term survivors].
An SG; Kim DU; Song GA; Jang AL
Korean J Gastroenterol; 2014 Dec; 64(6):356-63. PubMed ID: 25530587
[TBL] [Abstract] [Full Text] [Related]
[Next]